Biography and Research Information
OverviewAI-generated summary
Meghan D. Jones is a graduate student at the University of Arkansas for Medical Sciences. Her research focuses on identifying and evaluating potential new therapeutic compounds. Her recent publication in 2024 details the synthesis and in vitro evaluation of disquaramide compounds, identifying them as a promising class of anti-leishmanial drugs. This work involved collaboration with researchers from the University of Central Arkansas and within her institution, including Gregory R. Naumiec, Alexx Weaver, Hayden Roys, and Anne K. Bowlin. Jones has one publication to her name, indicating recent activity in her field.
Metrics
- h-index: 3
- Publications: 9
- Citations: 24
Selected Publications
-
Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs (2024)
Collaboration Network
Top Collaborators
Hayden Roys
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Assyl Arykbayeva
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Sarah K. Friedman
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gabriel Gifford
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Eva R. Palmer
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alex Rogers
University of Central Arkansas (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Emily N. H. Tran
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Lucy Fry
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alexx Weaver
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Anne K. Bowlin
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Michael R. Eledge
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Karl W. Boehme
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gregory R. Naumiec
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Tiffany Weinkopff
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Similar Researchers
Based on overlapping research topics
Juarez Braga
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Computational Drug Discovery Methods
Microbial infections and disease research
M. I. Ali
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Microbial infections and disease research
Health and Medical Research Impacts
Jennifer Guimbellot
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Microbial infections and disease research
Health and Medical Research Impacts
Peng, Cheng
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Health and Medical Research Impacts
Mitchell Rotenberry
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Health and Medical Research Impacts
Helen Beneš
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Disease Mechanisms Research
Microbial infections and disease research